BAS-118

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBAS-118
Drug Alias NameBAS-118
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHelicobacter pylori infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi Tanabe Pharma
Active IndicationsN/A
Inactive IndicationsHelicobacter pylori infection

Other Information

ATC CodeN/A
Related LinksN/A